|
|
Article: Walter Reed Army Medical Center Seeks Palatin Technologies' LeuTech for Potential Early Detection of Inhaled Anthrax Infection.
- Article from:
- Business Wire
- Article date:
- November 5, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
BIOWIRE2K
PRINCETON, N.J.--(BW HealthWire)--Nov. 5, 2001
Palatin Technologies, Inc. (AMEX: PTN) announced today that it has teamed with the Walter Reed Army Medical Center, Washington, D.C. to evaluate the clinical utility of Palatin's investigational infection imaging and diagnostic product, LeuTech(R), for the early detection of inhalation anthrax.
Under the agreement, made through The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., study patients exposed to anthrax will begin receiving LeuTech(R) scans this week. LeuTech(R) is a radiolabeled monoclonal antibody ...